The molecule, HMBPP, works by stimulating red blood cells, says Ingrid Faye, researcher at the Department of Molecular Bioscience, Stockholm University (SU) and corresponding author of the study, published in Science this month (February 9).
“The more we understand the parasite and how it can be carried by the mosquito from one human to the next, the easier it will be to finds ways to defeat malaria.”
Ingrid Faye, Stockholm University
Faye and other researchers at SU, the Swedish University of Agricultural Science and Sweden’s KTH Royal Institute of Technology, focused their study on Anopheles gambiae. But they believe that other mosquito species react to HMBPP in the same way.
According to Faye if a malaria-infected mosquito bites an individual and that person develops the disease, the resulting infection would cause carbon dioxide and organic compounds aldehydes and monoterpenes to be released from the victim’s skin or breath. The odours “attract uninfected mosquitoes to bite and get the parasites themselves. Those mosquitoes will then carry on the transmission of malaria to another person”.
HMBPP not only attracts mosquitoes but also spur them to eat more blood, enabling the production of greater numbers of parasites, according to the study.
Michael Kanost, professor at the Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, says the study is important because it led to “the discovery of a chemical mechanism for the attraction of non-infected A. gambiae mosquitoes to people who already are infected with malaria.”
Kanost believes HMBPP, could be helping the malaria parasite increase the transmission of malaria within human populations, as non-infected mosquitoes “are more likely to bite infected individuals and obtain the parasite themselves.” “The more we understand the parasite and how it can be carried by the mosquito from one human to the next, the easier it will be to finds ways to defeat malaria,” says Faye, adding that one way would be to devise mosquito traps that uses attractant molecules similar to those that HMBPP causes red blood cells to produce.
Insecticides used to control mosquito populations are toxic and prone to developing resistance. Since the parasite also grows resistant to drugs, new methods of fighting the disease are being constantly developed. According to the World Health Organization there are over 200 million cases of malaria worldwide and 430,000 deaths, 90 per cent of which in Africa.
This piece was produced by SciDev.Net’s Asia & Pacific desk.